Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer
ConclusionsNumber rather than location of EPMS is a prognostic factor in patients with stage IV M1b NSCLC. This information is relevant for accurate prognostication, stratification of participants in future clinical trials, and timely and appropriate advanced care planning.
Source: Medical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Clinical Trials | Databases & Libraries | Liver | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Smokers | Urology & Nephrology